APPLICATION
ANDA064187
TYPE
ANDA
ORIGINAL APPROVAL
1997-09-30
LATEST ACTION
2008-05-28
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued
Products
ERYTHROMYCINDiscontinued
ERYTHROMYCIN 2% · SOLUTION · TOPICAL
Approval history
2008-05-28Labeling · Supplement 4AP
1997-09-30OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.